Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Accumulated Expenses (2022 - 2023)

Historic Accumulated Expenses for 60 Degrees Pharmaceuticals (SXTPW) over the last 2 years, with Q4 2023 value amounting to $75000.0.

  • 60 Degrees Pharmaceuticals' Accumulated Expenses fell 7692.31% to $75000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $75000.0, marking a year-over-year decrease of 7692.31%. This contributed to the annual value of $75000.0 for FY2023, which is 7692.31% down from last year.
  • 60 Degrees Pharmaceuticals' Accumulated Expenses amounted to $75000.0 in Q4 2023, which was down 7692.31% from $295000.0 recorded in Q2 2023.
  • 60 Degrees Pharmaceuticals' Accumulated Expenses' 5-year high stood at $325000.0 during Q4 2022, with a 5-year trough of $75000.0 in Q1 2023.